Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EPS8L3 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-09 |
mRNA | BARD1 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-09 |
mRNA | CRLF3 | CTRPv2 | pan-cancer | AAC | -0.23 | 9e-09 |
mRNA | C10orf90 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-09 |
mRNA | TBCCD1 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-09 |
mRNA | LIN54 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
mRNA | PSIP1 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |
mRNA | SMARCC2 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
mRNA | RP11-762I7.5 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
mRNA | HLTF | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |